Structural and symptomatic efficacy of glucosamine and chondroitin: relevant financial interest?

Arch Intern Med. 2004 Feb 9;164(3):338-9; author reply 339. doi: 10.1001/archinte.164.3.338-c.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Chondroitin / economics
  • Chondroitin / therapeutic use*
  • Dietary Supplements* / economics
  • Disclosure
  • Glucosamine / economics
  • Glucosamine / therapeutic use*
  • Humans
  • Osteoarthritis, Knee / drug therapy*
  • Osteoarthritis, Knee / economics
  • Pain Measurement / economics
  • Research Support as Topic*

Substances

  • Chondroitin
  • Glucosamine